Peptic Ulcer clinical trials
The registry lists 146 studies for Peptic Ulcer across more than 10 countries. 25 are recruiting or about to start. 88 of them are mainly about Peptic Ulcer (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-06. Counting its 4 narrower conditions too, such as Stomach Ulcer: 377 studies, 58 open.
Get an email when these change. Save the Peptic Ulcer studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
AstraZeneca (9) · Chinese University of Hong Kong (8) · Shanghai Jiao Tong University School of Medicine (6) · Xijing Hospital of Digestive Diseases (5) · Kaohsiung Veterans General Hospital. (5) · Yongquan Shi (3) · Daewoong Pharmaceutical Co. LTD. (3) · Damascus Hospital (3)
What is being tested here
Drugs under test in Peptic Ulcer studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Aspirin | 1 | 1 | 8 |
| Omeprazole | 1 | 0 | 5 |
| Fexuprazan | 1 | 2 | 2 |
| Levofloxacin | 1 | 0 | 1 |
| Tegoprazan | 1 | 0 | 1 |
| Zastaprazan | 1 | 1 | 1 |
| Esomeprazole | 0 | 2 | 9 |
| Pantoprazole | 0 | 2 | 5 |
| Lansoprazole | 0 | 2 | 4 |
| Metronidazole | 0 | 0 | 3 |
Drug classes tested here Proton pump inhibitors (PPIs) 1 open · NSAIDs 1 open · H2 blockers 4
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
All 6, phase 3 first
- Aug 2027Study to Evaluate the Efficacy and Safety of JP-1366 in the Prevention of NSAIDs-Induced Peptic Ulcers · Phase 3 · Onconic Therapeutics Inc.
- Aug 2027Study to Evaluate the Efficacy and Safety of Ilaprazole 10 mg in Prevention NSAIDs Associated Peptic Ulcer · Phase 3 · Il-Yang Pharm. Co., Ltd.
- Dec 2026Prevention of Recurrent Ulcer Bleeding in Patients With Idiopathic Gastroduodenal Ulcer · Chinese University of Hong Kong
- Mar 2027OPEN Versus InTact Capsule Proton Pump Inhibitors for the Treatment of Marginal Ulcers · Stephen Firkins
- Apr 2027Predicting Peptic Complications Using H. Pylori Serology and Gastric Ultrasound · Assiut University
- Apr 2027Fexuclue for Prevention of NSAIDs-Induced Peptic Ulcer in Real-World Practice · Daewoong Pharmaceutical Co. LTD.
Who these studies take
Of the 18 Peptic Ulcer studies recruiting now, 11 (61%) set no upper age limit and 7 (39%) stop at 75 or younger. 3 (17%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 1 (6%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 3 (17%) | 3 (17%) |
| 18 | 13 (72%) | 13 (72%) |
| 30 | 16 (89%) | 16 (89%) |
| 40 | 16 (89%) | 16 (89%) |
| 50 | 16 (89%) | 16 (89%) |
| 65 | 16 (89%) | 16 (89%) |
| 75 | 12 (67%) | 12 (67%) |
| 85 | 11 (61%) | 11 (61%) |
Across all 146 studies, recruiting or not: 32% stop at 75 or younger and 14% at 65; 12% take children; 0% are for women only and 0% for men only; 16% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 50 of 146. Browse all 146 → or search them.
- Potassium-Competitive Acid Blocker Versus pROton-Pump Inhibitor for GastroproTECTion Strategies In Patients at High Gastro-Intestinal Bleeding Risk Receiving Antithrombotic TherapyRecruitingNCT04416581Phase 41 country
- Phase 3 to Evaluate the Efficacy and Safety of DWP14012 in Patients With Gastric UlcerNot yet recruitingNCT07730138Phase 32 countries
- Marginal Ulcer Healing With Low-Thermal Argon Plasma Endoscopic TreatmentRecruitingNCT06543316Not applicable1 country
- Randomized Trial of UI-EWD vs. Conventional Endoscopic Therapy for Nonvariceal Upper Gastrointestinal BleedingRecruitingNCT06188585Not applicable6 countries
- Vonoprazan High-Dose Dual VS Levofloxacin ConcomitantNot yet recruitingNCT07624422Phase 41 country
- The Transit Bipartition With the Use of a Metallic Anastomosis Clip and Circular Fundocorporeal GastroplicationRecruitingNCT07495020Not applicable1 country
- Fexuclue for Prevention of NSAIDs-Induced Peptic Ulcer in Real-World PracticeNot yet recruitingNCT075587071 country
- OPEN Versus InTact Capsule Proton Pump Inhibitors for the Treatment of Marginal UlcersRecruitingNCT05799105Phase 41 country
- Predicting Peptic Complications Using H. Pylori Serology and Gastric UltrasoundNot yet recruitingNCT07458490
- CURE-H. Pylori: A Trial on the Combination of Anti-Ulcerants and Levofloxacin-Based Therapy for Helicobacter Pylori EradicationRecruitingNCT07344506Phase 41 country
- The Effect of Vascular Imaging Devices on Success Rates of Peripheral Vascular Access in Pediatric PatientsNot yet recruitingNCT073157111 country
- Outcome Analysis of POEM and Endoluminal TherapiesEnrolling by invitationNCT03123835Not applicable1 country
- Saccharomyces Boulardii Combined With Bismuth Quadruple Therapy for Helicobacter Pylori Rescue TreatmentRecruitingNCT07139366Phase 41 country
- Treatment Efficacy of Regimens With and Without Bismuth in Children With Helicobacter Pylori-Associated Peptic Ulcer DiseaseRecruitingNCT07260006Not applicable1 country
- Efficacy Comparison of Vonoprazan Combined With Different Antibiotics in Dual Therapy for Helicobacter Pylori Eradication: A Prospective, Randomized Controlled Clinical TrialRecruitingNCT07068607Phase 41 country
- Tegoprazan And Lansoprazole Effectiveness in Bleeding Peptic Ulcer TreatmentRecruitingNCT06894992Not applicable1 country
- Coated or Chewable Aspirin and a Hybrid Strategy to Mitigate Adverse Effects of Air Pollution in Stable Atherosclerotic DiseaseRecruitingNCT06541691Not applicable1 country
- RAK-PRIDE: Optimizing Proton Pump Inhibitor Use Through Education and InterventionRecruitingNCT06858384Not applicable1 country
- Study to Evaluate the Efficacy and Safety of JP-1366 in the Prevention of NSAIDs-Induced Peptic UlcersRecruitingNCT06439563Phase 31 country
- Hemostatic Forceps vs. Bipolar Electrocautery Probes for High-Risk Bleeding Gastroduodenal UlcersRecruitingNCT06393907Not applicable1 country
- Ulcers Formation After Hand-Sewn vs Stapled Gastrojejunal Anastomosis In MGB.RecruitingNCT06077955Not applicable1 country
- Prevention of Recurrent Ulcer Bleeding in Patients With Idiopathic Gastroduodenal UlcerRecruitingNCT03675672Phase 41 country
- Prevalence and Risk Factors of Helicobacter Pylori Infection in Children and Young AdultsRecruitingNCT058303571 country
- Diosmin as Adjuvant Therapy in Treatment of Non-bleeding Peptic UlcerRecruitingNCT05670457Phase 31 country
- Volatiles in Breath and Headspace Analysis - Diagnostic MarkersEnrolling by invitationNCT032280951 country
- Study to Evaluate the Efficacy and Safety of Ilaprazole 10 mg in Prevention NSAIDs Associated Peptic UlcerActive, not recruitingNCT06284876Phase 31 country
- To Develop Methods for the Rehabilitation of Chronic Gastroduodenal Pathology in Children.Active, not recruitingNCT04702542Not applicable1 country
- Vonoprazan-based Versus Esomeprazole-based Triple Therapy for Helicobacter Pylori EradicationCompletedNCT07537634Phase 41 country
- Study to Evaluate the Safety, Efficacy of Tegoprazan for the Prevention of PUD in Patients on Treatment With NSAIDsCompletedNCT04840550Phase 31 country
- Comparative Effectiveness of Triple Versus Quadruple Therapy in the Treatment of Helicobacter Pylori Induced GastritisCompletedNCT07312721Phase 41 country
- Ulcer Pomegranate MuffinsCompletedNCT07123259Not applicable1 country
- Risk Factors Affecting Mortality in Perforated Peptic UlcerCompletedNCT070501991 country
- Effects of High-dose Dual Therapy and Bismuth Quadruple Therapy for Helicobacter Pylori Eradication on Intestinal MicroecologyCompletedNCT05742568Phase 41 country
- Helicobacter Rescue Therapy With Vonorazon and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple TherapyCompletedNCT06168084Phase 41 country
- Efficacy and Safety Study of HZT-501 in Reducing the Risk of Ibuprofen-associated UlcersCompletedNCT00450658Phase 3
- Study to Evaluate the Efficacy and Safety of DWP14012 in Prevention of NSAIDs Induced Peptic UlcerCompletedNCT04784910Phase 31 country
- Efficacy and Safety of Hou Gu Mi Xi in Patients With Peptic Ulcer DiseasesCompletedNCT03320538Not applicable1 country
- Inventory of Inappropriate Prescriptions of Proton Pump Inhibitors (PPIs) in People Over 75 Years of AgeCompletedNCT056182491 country
- Management of Perforated Peptic UlcerCompletedNCT056996161 country
- Minimally Invasive Evaluation of Dyspepsia by Combined Magnetically Controlled Capsule Endoscopy and Urea Breath Test: a Pilot Prospective Cohort StudyCompletedNCT04918472Not applicable1 country
- Proton Pump Inhibitor Preventing Upper Gastrointestinal Injury In Patients On Dual Antiplatelet Therapy After CABGActive, not recruitingNCT03908593Phase 41 country
- Anticoagulation With Enhanced Gastrointestinal Safety (AEGIS) TrialCompletedNCT05085405Not applicable1 country
- Precise Delivery of Tranexamic Acid to Enhance Endoscopic Hemostasis for Peptic Ulcer BleedingCompletedNCT05248321Not applicable1 country
- Effect of ALBIS on Gastroduodenal Mucosal Injury in Patients Receiving Dual Antiplatelet Therapy After Percutaneous Coronary InterventionCompletedNCT02175186Phase 41 country
- Helicobacter Rescue Therapy With High-dose Esomeprazole and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple TherapyCompletedNCT04678492Phase 41 country
- Registry for Upper Gastrointestinal BleedingCompletedNCT042111941 country
- Helicobacter Pylori Eradication With Probiotics Combined With Triple Therapy Versus Bismuth-containing Quadruple TherapyCompletedNCT05237115Phase 41 country
- Effectiveness of GastimunHp Plus in Supporting the Treatment of Peptic Ulcer Disease With Helicobacter Pylori InfectionTerminatedNCT04025983Not applicable1 country
- S-CEI of Nexium in Paediatric PatientsCompletedNCT035620261 country
- Endoscopic Diagnosis and Treatment of Acute Nonvariceal Upper Gastrointestinal BleedingCompletedNCT04895904